A specialized center for treating intestinal diseases has opened in Almaty.

The first of its kind in Kazakhstan, this center focuses on the treatment of inflammatory bowel diseases (IBD), short bowel syndrome (SBS), and nutritional correction. Established at the National Research Institute of Cardiology and Internal Medicine, it marks a significant step forward in the development of medical care in the country. The center’s uniqueness lies in its combination of advanced diagnostic technologies, comprehensive therapy options, and a multidisciplinary team of highly qualified specialists, allowing patients to receive holistic care and rehabilitation in one place.

In recent years, inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, have become increasingly relevant both globally and in Kazakhstan. IBD is affecting an ever-growing number of people. According to statistics, approximately 5-10 cases of IBD are reported for every 100,000 people in Kazakhstan, and this number is likely to rise in the coming years due to improved diagnostics and greater public awareness. It is important to highlight that conditions like Crohn's disease and ulcerative colitis require serious attention and an individualized approach to treatment, and the new center provides the necessary facilities for this.

Another significant issue faced by patients is short bowel syndrome. This rare yet severe condition typically arises after the surgical removal of substantial portions of the small intestine, often due to trauma, diseases, or complications from IBD. People with short bowel syndrome often struggle with nutrient absorption, which demands specialized treatment and support for their condition. The new center in Almaty will offer cutting-edge therapy methods and comprehensive nutritional correction for these patients.

Thus, the opening of this specialized center in Almaty is an important milestone in improving medical care in Kazakhstan. Patients will now be able to receive expert treatment, rehabilitation, and personalized nutritional support. With the increasing prevalence of these diseases and advances in diagnostic capabilities, the center will play a pivotal role in combating serious intestinal diseases and enhancing the quality of life for those suffering from these conditions.